But here goes. So a drug, denosumab (or Prolia) used to to treat osteoporosis appears to prevent growth of breast cancer in high risk (read BRCA1+) women. This could be a prevention strategy for this group of women. This sounds like fantastic news.
So its a little tiny group. I am not sure that I am too impressed with the size of this group. And that the results were published based on such a small group.
You would think that since the drug is approved already it would be fairly quick to be available for this use but since the clinical trials will take so long to see if cancer growth is prevented it will take ten years to get through trials and then FDA approval, and then finally available.
As the article concludes it might be a solution for future generations. I am just a little deflated as I went from high expectations to a long wait.